Prevalence of Fabry Disease among Patients with Parkinson's Disease.
Parkinson'S Disease
Lackova, Alexandra A; Beetz, Christian C; Oppermann, Sebastian S; Bauer, Peter P; Pavelekova, Petra P; Lorincova, Tatiana T; Ostrozovicova, Miriam M; Kulcsarova, Kristina K; Cobejova, Jana J; Cobej, Martin M; Levicka, Petra P; Liesenerova, Simona S; Sendekova, Daniela D; Sukovska, Viktoria V; Gdovinova, Zuzana Z; Han, Vladimir V; Rizig, Mie M; Houlden, Henry H; Skorvanek, Matej M
Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease.
International Journal Of Molecular Sciences
Lukas, Jan J; Cimmaruta, Chiara C; Liguori, Ludovica L; Pantoom, Supansa S; Iwanov, Katharina K; Petters, Janine J; Hund, Christina C; Bunschkowski, Maik M; Hermann, Andreas A; Cubellis, Maria Vittoria MV; Rolfs, Arndt A
Xiao, Ke K; Lu, Dongchao D; Hoepfner, Jeannine J; Santer, Laura L; Gupta, Shashi S; Pfanne, Angelika A; Thum, Sabrina S; Lenders, Malte M; Brand, Eva E; Nordbeck, Peter P; Thum, Thomas T
A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry disease.
Human Mutation
Wu, Xiaoyang X; Katz, Evan E; Della Valle, Maria Cecilia MC; Mascioli, Kirsten K; Flanagan, John J JJ; Castelli, Jeffrey P JP; Schiffmann, Raphael R; Boudes, Pol P; Lockhart, David J DJ; Valenzano, Kenneth J KJ; Benjamin, Elfrida R ER